Previous studies (35, 37) have identified E2F8 as a biomarker for colon cancer, but they did not evaluate the potential role of SNHG1-RFWD3-E2F8 ceRNA network interaction in rectum cancer. This evidence concerns the gene E2F8 and malignant colon neoplasm.